carbon monoxide has been researched along with Helicobacter Infections in 1 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higo, S | 1 |
| Takeuchi, H | 1 |
| Yamamoto, H | 1 |
| Hino, T | 1 |
| Kawashima, Y | 1 |
1 other study available for carbon monoxide and Helicobacter Infections
| Article | Year |
|---|---|
Slow release of tetracycline from a mucoadhesive complex with sucralfate for eradication of Helicobacter pylori.
Topics: Adhesiveness; Anti-Bacterial Agents; Carbon Monoxide; Chemistry, Pharmaceutical; Delayed-Action Prep | 2008 |